Rifampicin Antibiotic Resistance Level Positive TB Results with Molecular Rapid Test (MRT) in Mataram City Hospital
- DOI
- 10.2991/978-94-6463-018-3_16How to use a DOI?
- Keywords
- Mycobacterium tuberculosis; Tuberculosis; Resistance; Rifampicin
- Abstract
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. Tuberculosis is the most dangerous infectious disease in the world. The purpose of this study was to determine the level of antibiotic resistance to rofampicin on positive TB results in the Mataram City Hospital. In this research, the research method used is analytic observational. The research data used is in the form of secondary data, which comes from the tuberculosis examination report book. In this study, the research sample was 290 samples during the January-December 2019 examination period at the Mataram City Hospital. The results indicated that at the Mataram City Hospital, there were 11 samples (4%) that were not resistant to the antibiotic rifampin and 275 samples (95%) were still sensitive and 4 other samples (1%) could not be determined to the antibiotic.
- Copyright
- © 2023 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Aini Aini AU - Ika Nurfajri Mentari AU - Muhammad Aminul Mukarram PY - 2022 DA - 2022/12/15 TI - Rifampicin Antibiotic Resistance Level Positive TB Results with Molecular Rapid Test (MRT) in Mataram City Hospital BT - Proceedings of the First International Conference on Medical Technology (ICoMTech 2021) PB - Atlantis Press SP - 123 EP - 129 SN - 2468-5739 UR - https://doi.org/10.2991/978-94-6463-018-3_16 DO - 10.2991/978-94-6463-018-3_16 ID - Aini2022 ER -